Medicines for human use under evaluation
Each month, the European Medicines Agency's (EMA) publishes an updated list of medicines for human use currently under evaluation by EMA’s Committee for Medicinal Products for Human Use (CHMP) to obtain a marketing authorisation in the European Union (EU).
For information on treatments and vaccines for COVID-19, including those under evaluation by the CHMP:
The CHMP meets once per month. Its evaluations of marketing authorisation applications submitted through the centralised procedure provide the basis for authorisation of medicines in Europe.
Monthly lists of medicines under evaluation by the CHMP are available dating back to 2012. They contain the international non-proprietary names (INN) and therapeutic areas of innovative medicines. The INN contains only the active moiety for generic medicines and biosimilar medicines, with no information on salt, ester or derivative. The lists are available in Excel format from February 2021 to support data sorting and filtering.
The CHMP's independent recommendations on medicine for human use are based on a comprehensive scientific evaluation of data. For information on how EMA evaluates medicines and the CHMP's role in the authorisation of medicines in the EU:
-
List item
Applications for new human medicines under evaluation by the CHMP: June 2023 (XLSX/98.82 KB) (new)
First published: 09/06/2023
EMA/207108/2023 -
List item
Applications for new human medicines under evaluation by the CHMP: May 2023 (XLSX/98.47 KB) (new)
First published: 10/05/2023
EMA/207107/2023 -
List item
Applications for new human medicines under evaluation by the CHMP: April 2023 (XLSX/98.65 KB)
First published: 14/04/2023
EMA/164278/2023 -
List item
Applications for new human medicines under evaluation by the CHMP: March 2023 (XLSX/98.73 KB)
First published: 09/03/2023
EMA/104578/2023 -
List item
Applications for new human medicines under evaluation by the CHMP: February 2023 (XLSX/99.09 KB)
First published: 10/02/2023
Last updated: 14/02/2023
EMA/58424/2023 corr -
List item
Applications for new human medicines under evaluation by the CHMP: January 2023 (XLSX/98.73 KB)
First published: 12/01/2023
EMA/13171/2023
-
List item
Applications for new human medicines under evaluation by the CHMP: December 2022 (XLSX/98.77 KB)
First published: 12/12/2022
EMA/932370/2022 -
List item
Applications for new human medicines under evaluation by the CHMP: November 2022 (XLSX/109.4 KB)
First published: 03/11/2022
EMA/855051/2022 -
List item
Applications for new human medicines under evaluation by the CHMP: October 2022 (XLSX/110.58 KB)
First published: 13/10/2022
EMA/822461/2022 -
List item
Applications for new human medicines under evaluation by the CHMP: September 2022 (XLSX/111 KB)
First published: 27/09/2022
EMA/784941/2022 -
List item
Applications for new human medicines under evaluation by the CHMP: August 2022 (XLSX/98.16 KB)
First published: 10/08/2022
EMA/685123/2022 -
List item
Applications for new human medicines under evaluation by the CHMP: July 2022 (XLSX/110.1 KB)
First published: 08/07/2022
EMA/623957/2022 -
List item
Applications for new human medicines under evaluation by the CHMP: June 2022 (XLSX/98.61 KB)
First published: 08/06/2022
EMA/564600/2022 -
List item
Applications for new human medicines under evaluation by the CHMP: May 2022 (XLSX/98.68 KB)
First published: 16/05/2022 -
List item
Applications for new human medicines under evaluation by the CHMP: April 2022 (XLSX/98.89 KB)
First published: 08/04/2022
EMA/203848/2022 -
List item
Applications for new human medicines under evaluation by the CHMP: March 2022 (XLSX/99.24 KB)
First published: 11/03/2022
Last updated: 23/03/2022
EMA/144373/2022 Corr. -
List item
Applications for new human medicines under evaluation by the CHMP: February 2022 (XLSX/100.15 KB)
First published: 04/02/2022
Last updated: 23/03/2022
EMA/71693/2022 Corr. -
List item
Applications for new human medicines under evaluation by the CHMP: January 2022 (XLSX/99.26 KB)
First published: 07/01/2022
EMA/4718/2022
-
List item
Applications for new human medicines under evaluation by the CHMP: December 2021 (XLSX/99.69 KB)
First published: 08/12/2021
EMA/726376/2021 -
List item
Applications for new human medicines under evaluation by the CHMP: November 2021 (XLSX/775.78 KB)
First published: 08/11/2021
EMA/625035/2021 -
List item
Applications for new human medicines under evaluation by the CHMP: October 2021 (XLSX/99.12 KB)
First published: 08/10/2021
EMA/569084/2021 -
List item
Applications for new human medicines under evaluation by the CHMP: September 2021 (XLSX/99.19 KB)
First published: 02/09/2021
EMA/491283/2021 -
List item
Applications for new human medicines under evaluation by the CHMP: August 2021 (XLSX/98.77 KB)
First published: 09/08/2021
EMA/444323/2021 -
List item
Applications for new human medicines under evaluation by the CHMP: July 2021 (XLSX/98.69 KB)
First published: 09/07/2021
EMA/373584/2021 -
List item
Applications for new human medicines under evaluation by the CHMP: June 2021 (XLSX/98.72 KB)
First published: 07/06/2021
EMA/316655/2021 -
List item
Applications for new human medicines under evaluation by the CHMP: May 2021 (XLSX/98.71 KB)
First published: 17/05/2021
EMA/247078/2021 -
List item
Applications for new human medicines under evaluation by the CHMP: April 2021 (XLSX/98.27 KB)
First published: 26/04/2021
EMA/201519/2021 -
List item
Applications for new human medicines under evaluation by the CHMP: March 2021 (XLSX/98.09 KB)
First published: 12/03/2021
EMA/151574/2021 -
List item
Applications for new human medicines under evaluation by the CHMP: February 2021 (XLSX/97.28 KB)
First published: 10/02/2021
EMA/75461/2021 -
List item
Applications for new human medicines under evaluation by the CHMP: January 2021 (PDF/104.11 KB)
First published: 11/01/2021
EMA/1722/2021